These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25483689)

  • 41. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago.
    Wang LY; Lin HH
    Vaccine; 2007 Oct; 25(41):7160-7. PubMed ID: 17707557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.
    Yao J; Shan H; Chen Y; Jiang ZG; Dai XW; Ren JJ; Xu KJ; Ruan B; Yang SG; Li Q
    Hum Vaccin Immunother; 2015; 11(5):1114-9. PubMed ID: 25692413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: a 5-year follow-up study].
    Wu WL; Yan BY; Lyu JJ; Liu JY; Feng Y; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):484-90. PubMed ID: 27256726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
    Posuwan N; Wanlapakorn N; Vongpunsawad S; Sintusek P; Leuridan E; Van Damme P; Poovorawan Y
    Vaccine; 2020 Feb; 38(7):1643-1651. PubMed ID: 31948817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors.
    Stefanati A; Bolognesi N; Sandri F; Dini G; Massa E; Montecucco A; Lupi S; Gabutti G
    J Prev Med Hyg; 2019 Sep; 60(3):E184-E190. PubMed ID: 31650052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine.
    Van Der Meeren O; Bleckmann G; Crasta PD
    Hum Vaccin Immunother; 2014; 10(6):1682-7. PubMed ID: 24637296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults.
    Li J; Meng F; Zheng J; Liang Q; Li H; Li J; Zhang L; Gan J; Zhu F
    Hum Vaccin Immunother; 2021 Aug; 17(8):2762-2767. PubMed ID: 33735590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.
    Wu TW; Chu CC; Liao HW; Lin SK; Ho TY; Lin M; Lin HH; Wang LY
    Genes Immun; 2014 Jan; 15(1):47-53. PubMed ID: 24285177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Leroux-Roels G; Crasta PD; Hardt K
    Hum Vaccin Immunother; 2012 Jul; 8(7):896-904. PubMed ID: 22777097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study.
    Spada E; Romanò L; Tosti ME; Zuccaro O; Paladini S; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti CM; Mele A; Zanetti AR;
    Clin Microbiol Infect; 2014 Oct; 20(10):O680-6. PubMed ID: 24528380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.
    Agladioglu S; Beyazova U; Camurdan AD; Sahin F; Atak A
    Infection; 2010 Aug; 38(4):269-73. PubMed ID: 20512395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of three booster doses hepatitis B vaccine on the persistence of immune-protection among infants with normal and high antibody response to primary vaccination: a matched case-control study].
    Feng Y; Lyu J; Liu J; Yan B; Song L; Liang X; Li L; Zhang G; Wang F; Zhang L; Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):460-3. PubMed ID: 27087206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Nagashima S; Yamamoto C; Ko K; Chuon C; Sugiyama A; Ohisa M; Akita T; Katayama K; Yoshihara M; Tanaka J
    Vaccine; 2019 Jan; 37(1):145-151. PubMed ID: 30449632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.
    Lu S; Ren J; Li Q; Jiang Z; Chen Y; Xu K; Ruan B; Yang S; Xie T; Yang L; Li J; Yao J
    Hum Vaccin Immunother; 2017 Apr; 13(4):903-908. PubMed ID: 27905821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: A 5-year follow-up study.
    Wu Z; Yao J; Bao H; Chen Y; Lu S; Li J; Yang L; Jiang Z; Ren J; Xu KJ; Ruan B; Yang SG; Xie TS; Li Q
    Hum Vaccin Immunother; 2018 May; 14(5):1251-1256. PubMed ID: 29337651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune response to different types of hepatitis B vaccine booster doses 2-32 years after the primary immunization schedule and its influencing factors.
    Zhao YL; Pan LL; Hao ZY; Jin F; Zhang YH; Li MJ; Zhang XJ; Han BH; Zhou HS; Ma TL; Wang F; Ma JC; Shen LP; Li Q
    Int J Infect Dis; 2020 Apr; 93():62-67. PubMed ID: 32004687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.